Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 108, Issue 1, Pages -
Publisher
Oxford University Press (OUP)
Online
2015-11-08
DOI
10.1093/jnci/djv292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Structure of Clinical Translation:Efficiency, Information, and Ethics
- (2015) Jonathan Kimmelman et al. HASTINGS CENTER REPORT
- A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma
- (2014) B. Rini et al. ANNALS OF ONCOLOGY
- Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial
- (2014) A. Adenis et al. ANNALS OF ONCOLOGY
- Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours
- (2014) N A G Lankheet et al. BRITISH JOURNAL OF CANCER
- A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies
- (2014) Justine Yang Bruce et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma
- (2014) Robert J. Motzer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia
- (2014) Vincent Castonguay et al. GYNECOLOGIC ONCOLOGY
- A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma
- (2014) Evan J. Wuthrick et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- How to increase value and reduce waste when research priorities are set
- (2014) Iain Chalmers et al. LANCET
- Increasing value and reducing waste in research design, conduct, and analysis
- (2014) John P A Ioannidis et al. LANCET
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Phase I Study of Sunitinib in Combination With Gemcitabine and Capecitabine for First-Line Treatment of Metastatic or Unresectable Renal Cell Carcinoma
- (2014) J. Bellmunt et al. ONCOLOGIST
- Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study
- (2014) Carmen Balaña et al. Targeted Oncology
- Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer
- (2013) Giuseppe Curigliano et al. BREAST
- Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma
- (2013) Petros D. Grivas et al. CANCER
- Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
- (2013) Hye Ryun Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases
- (2013) Christine Chevreau et al. Clinical Genitourinary Cancer
- A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
- (2013) David S. Hong et al. Clinical Genitourinary Cancer
- A phase II study of sunitinib in advanced hepatocellular carcinoma
- (2013) Carlo Barone et al. DIGESTIVE AND LIVER DISEASE
- Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial
- (2013) Michele Reni et al. EUROPEAN JOURNAL OF CANCER
- Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial
- (2013) Craig Reynolds et al. INVESTIGATIONAL NEW DRUGS
- A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)
- (2013) Markus Hutterer et al. NEURO-ONCOLOGY
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program
- (2013) Spencer Hey et al. Trials
- Development Times, Clinical Testing, Postmarket Follow-up, and Safety Risks for the New Drugs Approved by the US Food and Drug Administration
- (2013) Thomas J. Moore et al. JAMA Internal Medicine
- Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
- (2012) J.- L. Lee et al. ANNALS OF ONCOLOGY
- A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy
- (2012) K. H. Baumann et al. ANNALS OF ONCOLOGY
- Phase II open-label study of sunitinib in patients with advanced breast cancer
- (2012) Denise A. Yardley et al. BREAST CANCER RESEARCH AND TREATMENT
- Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure
- (2012) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma
- (2012) Nizar M. Tannir et al. EUROPEAN UROLOGY
- A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma
- (2012) Susana M. Campos et al. GYNECOLOGIC ONCOLOGY
- Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: A single-center experience with 31 patients
- (2012) Bruno Neri et al. INTERNATIONAL JOURNAL OF UROLOGY
- Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
- (2012) Tetsuhide Ito et al. INVESTIGATIONAL NEW DRUGS
- Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
- (2012) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
- (2012) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuous daily sunitinib for recurrent glioblastoma
- (2012) Teri Nguyen Kreisl et al. JOURNAL OF NEURO-ONCOLOGY
- A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma
- (2012) Edward Pan et al. JOURNAL OF NEURO-ONCOLOGY
- A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma
- (2012) Anna K. Nowak et al. Journal of Thoracic Oncology
- The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery
- (2012) Brian I. Rini et al. JOURNAL OF UROLOGY
- A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer
- (2012) Ji-Youn Han et al. LUNG CANCER
- A pilot study of sunitinib malate in patients with metastatic uveal melanoma
- (2012) Amit Mahipal et al. MELANOMA RESEARCH
- Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
- (2012) Charles C. L. Tong et al. PLoS One
- Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence
- (2012) Juping Zhao et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Dose Escalation and Pharmacokinetics Study of Enzastaurin and Sunitinib Versus Placebo and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- (2011) Manuela Schmidinger et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC
- (2011) N. G. Chau et al. ANNALS OF ONCOLOGY
- Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease
- (2011) E. Jonasch et al. ANNALS OF ONCOLOGY
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma
- (2011) Anne Flörcken et al. ANTI-CANCER DRUGS
- Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
- (2011) Ana M. Molina et al. CANCER
- Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study
- (2011) Steven G. DuBois et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
- (2011) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
- (2011) M. Moehler et al. EUROPEAN JOURNAL OF CANCER
- A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
- (2011) Jun Ho Yi et al. EUROPEAN JOURNAL OF CANCER
- Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs
- (2011) Laura J. Esserman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
- (2011) Scott A. Laurie et al. Journal of Thoracic Oncology
- Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer
- (2011) Bryan J. Schneider et al. Journal of Thoracic Oncology
- Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
- (2011) Sylvie Négrier et al. LANCET ONCOLOGY
- Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group
- (2011) Rena Buckstein et al. LEUKEMIA & LYMPHOMA
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II Study of Presurgical Sunitinib in Patients With Metastatic Clear-cell Renal Carcinoma and the Primary Tumor In Situ
- (2011) Axel Bex et al. UROLOGY
- A Phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)
- (2010) Viktor Grünwald et al. ACTA ONCOLOGICA
- Phase I/II Trial of Sunitinib Plus Gefitinib in Patients With Metastatic Renal Cell Carcinoma
- (2010) Robert J. Motzer et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study
- (2010) J. J. Biagi et al. ANNALS OF ONCOLOGY
- Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
- (2010) H. Wildiers et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
- (2010) Brian I. Rini et al. CANCER
- Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
- (2010) L. L. Carr et al. CLINICAL CANCER RESEARCH
- Phase II Study of Sunitinib in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
- (2010) Effrosyni Apostolidou et al. Clinical Lymphoma Myeloma & Leukemia
- Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma
- (2010) S. Tariq Mahmood et al. INTERNATIONAL JOURNAL OF CANCER
- A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate
- (2010) Justine Yang Bruce et al. INVESTIGATIONAL NEW DRUGS
- Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
- (2010) Ana M. Molina et al. INVESTIGATIONAL NEW DRUGS
- Phase II study of sunitinib as second-line treatment for advanced gastric cancer
- (2010) Yung-Jue Bang et al. INVESTIGATIONAL NEW DRUGS
- Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer
- (2010) David J. Gallagher et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of sunitinib malate in patients with recurrent high-grade glioma
- (2010) B. Neyns et al. JOURNAL OF NEURO-ONCOLOGY
- Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma
- (2010) Nicholas J. Hellenthal et al. JOURNAL OF UROLOGY
- Continuous Sunitinib Treatment in Patients with Advanced Hepatocellular Carcinoma: A Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) Multicenter Phase II Trial (SAKK 77/06)
- (2010) D. Koeberle et al. ONCOLOGIST
- A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)
- (2010) E. M. O'Reilly et al. ONCOLOGIST
- Publication Outcomes of Phase II Oncology Clinical Trials
- (2009) Rasmus T. Hoeg et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase II study of sunitinib in men with advanced prostate cancer
- (2009) M. Dror Michaelson et al. ANNALS OF ONCOLOGY
- Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
- (2009) S Novello et al. BRITISH JOURNAL OF CANCER
- A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
- (2009) George Fountzilas et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Study Combining Treatment with Temsirolimus and Sunitinib Malate in Patients with Advanced Renal Cell Carcinoma
- (2009) Premal H. Patel et al. Clinical Genitourinary Cancer
- 7122 Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma (mRCC): preliminary results
- (2009) C.H. Barrios et al. EJC SUPPLEMENTS
- Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
- (2009) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184
- (2009) Helen J. Mackay et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
- (2009) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Phase II study of sunitinib malate in head and neck squamous cell carcinoma
- (2009) Nicholas W. Choong et al. INVESTIGATIONAL NEW DRUGS
- Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
- (2009) Kuniaki Shirao et al. INVESTIGATIONAL NEW DRUGS
- A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
- (2009) H. Uemura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
- (2009) Suzanne George et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- (2009) Darren R. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2009) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
- (2009) Jean-Pascal H. Machiels et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function
- (2009) Reza Khosravan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
- (2009) Sandrine Faivre et al. LANCET ONCOLOGY
- Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib
- (2009) Katherine A. Janeway et al. PEDIATRIC BLOOD & CANCER
- Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer
- (2008) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2008) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma
- (2008) Anil A. Thomas et al. JOURNAL OF UROLOGY
- Life Cycle of Translational Research for Medical Interventions
- (2008) D. G. Contopoulos-Ioannidis et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started